查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1826795

2025年植入式心臟整流去颤器（ICD）全球市场报告

Implantable Cardioverter Defibrillators (ICDs) Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，植入式心臟整流去颤器(ICD) 市场规模强劲成长，从 2024 年的 37.6 亿美元增至 2025 年的 39.8 亿美元，复合年增长率为 5.8%。这段历史时期的成长可归因于心臟麻痹率的上升、植入式心臟整流去颤器在心臟麻痹二级预防中的应用、公众意识的增强、人口老龄化、政府和医疗机构的支持性政策以及医疗保健可及性的提高。

植入式心臟整流去颤器(ICD) 市场预计将在未来几年强劲成长，到 2029 年将达到 49.5 亿美元，复合年增长率为 5.6%。预测期内的成长归因于植入式心臟整流去颤器的接受度不断提高、对更个人化的心臟护理的需求不断增长、心律不整盛行率的上升以及新兴市场的需求不断增长。预测期内的主要趋势包括技术进步、无需经静脉导线的皮下 ICD 的引入、对具有起搏器功能的组合式 ICD 设备的需求、增强的感测和检测演算法、无线充电和电池技术的持续进步以及人工智慧 (AI) 在医疗保健和数据分析中的整合。

植入式心臟整流去颤器(ICD) 是一种小型装置，通常放置在靠近胸部的皮肤下。它用于监测心律，并在检测到危及生命的心律不整（例如室颤）时发出电击。 ICD 的主要目的是透过恢復正常心律来预防心臟麻痹。

ICD 有多种类型，包括单腔 ICD、双腔 ICD 和双心室 ICD。单腔 ICD 植入于胸腔，用于侦测并矫正某个心腔内的异常心律。这类装置用途广泛，包括治疗心搏过缓、心搏过速和心臟衰竭，并在医院、专科诊所和门诊手术中心等各种场所使用。

2025 年春季美国突然提高关税以及由此引发的贸易摩擦对医疗保健产业产生了重大影响，尤其是基本医疗设备、诊断设备和药品的供应。医院和医疗保健提供者正努力应对进口手术器械、诊断影像系统以及注射器和导管等消耗品成本的上涨，其中许多产品的国内替代品有限。这些不断上涨的成本使医疗保健预算捉襟见肘，导致一些医疗机构推迟设备升级或将增加的费用转嫁给患者。此外，原料和零件的关税扰乱了关键药品和医疗设备的生产，造成供应链延迟。作为应对措施，该行业正在采用多样化的筹资策略，尽可能扩大本地生产，并游说对关键医疗产品免关税。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供植入式心臟整流去颤器( ICD) 市场统计数据，例如全球市场规模、区域份额、竞争对手的市场份额，以及详细的植入式心臟整流去颤器(ICD) 细分市场、市场趋势和商业机会。本植入式心臟整流去颤器( ICD) 市场研究报告对该行业的现状和未来走势进行了详细分析，为您提供所需的一切观点。

未来五年5.6%的成长率预测比我们先前的预测略有下降0.1%。这一下降主要源自于美国与其他国家之间关税的影响。关税上涨可能会增加美国医院的负担，使其从爱尔兰和墨西哥进口的ICD组件和导线系统的成本增加，加剧心臟护理延误，并增加电生理实验室的成本。由于互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响，其影响也将更加广泛。

心血管疾病 (CVD) 的盛行率不断上升，预计将在未来几年推动植入式心臟整流去颤器(ICD) 市场的扩张。 CVD 是指影响心臟和血管的多种疾病，包括心臟病发作、中风和高血压。这些疾病通常与不良饮食、久坐不动的生活方式、吸烟和遗传易感性等因素有关。心血管疾病的增加主要是由于人口老化、不健康的生活方式以及肥胖、糖尿病和高血压等风险因素的增加。 ICD 在心血管疾病管理中发挥关键作用，它可以透过向有心臟麻痹风险的患者提供挽救生命的电击并恢復正常心律。例如，2023年12月，澳洲健康与福利研究所报告称，医生认证的因心臟疾病（CHD）导致的死亡人数有所增加，从2021年的14,100人增加到2022年的14,900人。因此，心血管疾病盛行率的上升正在推动ICD市场的成长。

植入式心臟整流去颤器(ICD) 市场的主要企业正专注于低电流去心房颤动等技术创新，以提高设备性能、延长电池寿命并增强患者舒适度。这些去心房颤动旨在以最小的功耗向心臟发送电击，从而延长电池寿命并确保有效治疗心律不整。例如，2023 年 10 月，法国医疗设备製造商微创 CRM 在日本推出了 ULYS植入式心臟整流去颤器(ICD) 和 INVICTA去心房颤动颤导线，标誌着心臟治疗技术的重要里程碑。这些设备具有先进的功能，例如低电流消耗以延长电池寿命和 MRI 相容性，适用于需要诊断成像的患者。 ULYS ICD 还具有 PARAD+ 心律不整辨识演算法和 AutoMRI 功能，可提高 MRI 扫描期间的患者安全性。此外，INVICTA导线在临床试验中表现出100%的植入成功率和97.4%的无併发症率，证明了其高度的可靠性和有效性。

2023年6月，总部位于荷兰的医疗科技公司荷兰皇家飞利浦与百多力公司（BIOTRONIK）合作，扩大飞利浦Symphony Suite心血管设备系列。 PhilipsSymphony Suite是一款领先的心血管门诊实验室（OBL）和门诊手术中心（ASC）解决方案。透过此次合作，飞利浦Symphony Suite将与百多力公司全面的心律管理和介入心臟病学产品相整合，从而改善个人化患者照护方案，并支持向院外护理的转变。百多力公司是一家总部位于美国的医疗设备製造商，专注于提供旨在改善心血管和血管内疾病患者生活品质的产品和服务。

植入式心臟整流去颤器(ICD) 市场涵盖治疗性去心房颤动、可充电和一次性电池、编程设备、植入工具、电极和导线的销售。该市场的价值为“出厂价”，即商品製造商或生产商向其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接向最终客户销售的商品价值。该市场中的商品价值还包括商品製造商提供的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球植入式心臟整流去颤器(ICD)：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球植入式心臟整流去颤器（ICD）市场：成长率分析
  • 全球植入式心臟整流去颤器(ICD) 市场表现：规模与成长，2019-2024 年
  • 全球植入式心臟整流去颤器(ICD) 市场预测：规模与成长，2024-2029 年，2034 年
  • 全球植入式心臟整流去颤器（ICD）：总目标市场（TAM）

第六章 市场细分

  • 全球植入式心臟整流去颤器(ICD) 市场：按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 单腔植入式心臟整流去颤器（ICD）
  • 植入式心臟整流去颤器（ICD）
  • 双心室装置
  • 全球植入式心臟整流去颤器(ICD) 市场：按应用、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 心搏过缓
  • 心搏过速
  • 心臟衰竭
  • 其他用途
  • 全球植入式心臟整流去颤器(ICD) 市场：依最终用户、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 专科诊所
  • 门诊手术中心
  • 其他最终用户
  • 全球植入式心臟整流去颤器(ICD) 市场：按类型细分（单植入式心臟整流去颤器(ICD)）、业绩及预测，2019-2024 年、2024-2029 年、2034 年
  • 标准单腔ICD
  • MRI相容单腔ICD
  • 无线单腔ICD
  • 全球植入式心臟整流去颤器(ICD) 市场：按双腔植入式心臟整流去颤器细分，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 标准双腔ICD
  • MRI相容双腔ICD
  • 无线双腔ICD
  • 全球植入式心臟整流去颤器(ICD) 市场：按双心室装置细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • CRT-D（心臟再同步治疗去心房颤动）
  • CRT-P（心臟再同步治疗心律调节器）
  • 具有先进功能（远端监控、无线功能）的双心室 ICD

第七章 区域和国家分析

  • 全球植入式心臟整流去颤器(ICD) 市场：区域分析、预测（2019-2024 年、2024-2029 年及 2034 年）
  • 全球植入式心臟整流去颤器(ICD) 市场：国家、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 植入式心臟整流去颤器(ICD) 市场：竞争格局
  • 植入式心臟整流去颤器(ICD) 市场：公司简介
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Koninklijke Philips NV Overview, Products and Services, Strategy and Financial Analysis
    • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • ZOLL Medical Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • St. Jude Medical Inc.
  • BIOTRONIK SE & Co. KG
  • Nihon Kohden Corporation
  • Fukuda Denshi Co. Ltd.
  • LivaNova PLC
  • MicroPort Scientific Corporation
  • Japan Lifeline Co. Ltd.
  • AtriCure Inc.
  • Physio-Control Inc.
  • BPL Medical Technologies Private Limited
  • Kestra Medical Technologies Inc.
  • CU Medical Germany GmbH
  • Metrax GmbH
  • Intermedics Inc.
  • Sorin Group SpA

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年植入式心臟整流去颤器（ICD）市场：提供新机会的国家
  • 2029年植入式心臟整流去颤器（ICD）市场：细分市场带来新机会
  • 植入式心臟整流去颤器(ICD) 市场 2029 年：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r33769u

Implantable cardioverter defibrillators (ICDs) are compact devices placed beneath the skin, usually near the chest area. They are designed to monitor the heart's rhythm and administer electrical shocks when a life-threatening arrhythmia, such as ventricular fibrillation, is identified. The primary goal of ICDs is to prevent sudden cardiac arrest by restoring a normal heart rhythm.

There are several types of implantable cardioverter defibrillators (ICDs), including single-chamber ICDs, dual-chamber ICDs, and biventricular devices. A single-chamber ICD is implanted in the chest and is responsible for detecting and correcting abnormal heart rhythms in one of the heart's chambers. This device serves various purposes, such as managing bradycardia, tachycardia, and heart failure, and is utilized in different settings, including hospitals, specialty clinics, ambulatory surgical centers, and more.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The implantable cardioverter defibrillators (ICDs) market research report is one of a series of new reports from The Business Research Company that provides implantable cardioverter defibrillators (ICDs) market statistics, including the implantable cardioverter defibrillators (ICDs) industry global market size, regional shares, competitors with the implantable cardioverter defibrillators (ICDs) market share, detailed implantable cardioverter defibrillators (ICDs) market segments, market trends, and opportunities, and any further data you may need to thrive in the implantable cardioverter defibrillators (ICDs) industry. This implantable cardioverter defibrillators (ICDs) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The implantable cardioverter defibrillators (icds) market size has grown strongly in recent years. It will grow from $3.76 billion in 2024 to $3.98 billion in 2025 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to increasing incidence of sudden cardiac arrest, inclusion of implantable cardioverter defibrillator in secondary prevention of sudden cardiac arrest, growing public awareness, rise in the aging population, supportive policies by governments and healthcare organizations, increased healthcare access.

The implantable cardioverter defibrillators (icds) market size is expected to see strong growth in the next few years. It will grow to $4.95 billion in 2029 at a compound annual growth rate (CAGR) of 5.6%. The growth in the forecast period can be attributed to growing acceptance of implantable defibrillators, rise in demand for more personalized cardiac care, rising prevalence of cardiac rhythm disorders, rising demand in emerging markets. Major trends in the forecast period include technological advancements, introduction of subcutaneous ICD that avoid transvenous leads, demand for combination ICD devices with pacemaker functionality, enhancing sensing and detection algorithms, continuous advancements in wireless charging and battery technology, integration of artificial intelligence (AI) in healthcare and data analytics.

The forecast of 5.6% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. hospitals by driving up the cost of ICD components and lead systems sourced from Ireland and Mexico, exacerbating cardiac care delays and increasing electrophysiology lab costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing prevalence of cardiovascular diseases (CVDs) is expected to drive the expansion of the implantable cardioverter defibrillators (ICDs) market in the coming years. CVDs are a range of disorders that impact the heart and blood vessels, including conditions such as heart attacks, strokes, and hypertension. These diseases are often linked to factors such as poor diet, sedentary lifestyle, smoking, and genetic predisposition. The rise in cardiovascular diseases is mainly attributed to aging populations, unhealthy lifestyle habits, and increasing rates of risk factors such as obesity, diabetes, and hypertension. ICDs play a critical role in managing CVDs by delivering life-saving electrical shocks to restore normal heart rhythms in individuals at risk of sudden cardiac arrest. For example, in December 2023, the Australian Institute of Health and Welfare reported a rise in doctor-certified deaths due to coronary heart disease (CHD), which increased from 14,100 in 2021 to 14,900 in 2022. Therefore, the increasing prevalence of cardiovascular diseases is fueling the growth of the ICD market.

Leading companies in the implantable cardioverter defibrillators (ICDs) market are concentrating on technological innovations, such as low current consumption defibrillators, to improve device performance, extend battery life, and enhance patient comfort. These defibrillators are designed to administer electrical shocks to the heart while using less energy, thereby increasing battery longevity and ensuring effective treatment of arrhythmias. For example, in October 2023, MicroPort CRM, a medical device company based in France, introduced the ULYS implantable cardioverter defibrillator (ICD) and the INVICTA defibrillation lead in Japan, marking a significant milestone in cardiac care technology. These devices incorporate advanced features such as low current consumption to extend battery life and MRI compatibility for patients requiring imaging procedures. The ULYS ICD also includes the PARAD+ arrhythmia discrimination algorithm and AutoMRI functionality, improving patient safety during MRI scans. Moreover, the INVICTA lead demonstrated a 100% implantation success rate and a 97.4% complication-free rate in clinical trials, showcasing its high reliability and effectiveness.

In June 2023, Royal Philips, a health technology company based in the Netherlands, joined forces with Biotronik to broaden the range of cardiovascular devices available to users of Philips SymphonySuite, a leading solution designed for cardiovascular office-based labs (OBLs) and ambulatory surgery centers (ASCs). The collaboration integrates Philips SymphonySuite with Biotronik's comprehensive selection of cardiac rhythm management and cardiovascular intervention products, thereby improving options for personalized patient care and supporting the shift towards out-of-hospital care settings. Biotronik, a US-based medical device company, specializes in providing products and services that aim to enhance the quality of life for patients with cardiovascular and endovascular conditions.

Major players in the implantable cardioverter defibrillators (ICDs) market are Abbott Laboratories, Medtronic Inc., Koninklijke Philips N.V., Boston Scientific Corporation, ZOLL Medical Corporation, St. Jude Medical Inc., BIOTRONIK SE & Co. KG, Nihon Kohden Corporation, Fukuda Denshi Co. Ltd., LivaNova PLC, MicroPort Scientific Corporation, Japan Lifeline Co. Ltd., AtriCure Inc., Physio-Control Inc., BPL Medical Technologies Private Limited, Kestra Medical Technologies Inc., CU Medical Germany GmbH, Metrax GmbH, Intermedics Inc., and Sorin Group S.p.A.

North America was the largest region in the implantable cardioverter defibrillators market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in implantable cardioverter defibrillators (ICDs) report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the implantable cardioverter defibrillators (ICDs) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The implantable cardioverter defibrillators (ICDs) market consists of sales of therapy defibrillators, rechargeable and non-rechargeable batteries, programming devices, implantation tools, electrodes, and leads. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Implantable Cardioverter Defibrillators (ICDs) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on implantable cardioverter defibrillators (icds) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for implantable cardioverter defibrillators (icds) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The implantable cardioverter defibrillators (icds) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Single Chamber Implantable Cardioverter Defibrillators (ICDs); Dual Chamber Implantable Cardioverter Defibrillators (ICDs); Biventricular Devices
  • 2) By Applications: Bradycardia; Tachycardia; Heart Failure; Other Applications
  • 3) By End User: Hospitals; Specialty Clinics; Ambulatory Surgical Centers; Other End Users
  • Subsegments:
  • 1) By Single Chamber Implantable Cardioverter Defibrillators (ICDs): Standard Single Chamber ICDs; MRI-Compatible Single Chamber ICDs; Wireless Single Chamber ICDs
  • 2) By Dual Chamber Implantable Cardioverter Defibrillators (ICDs): Standard Dual Chamber ICDs; MRI-Compatible Dual Chamber ICDs; Wireless Dual Chamber ICDs
  • 3) By Biventricular Devices: CRT-D (Cardiac Resynchronization Therapy Defibrillator); CRT-P (Cardiac Resynchronization Therapy Pacemaker); Biventricular ICDs With Advanced Features (Remote Monitoring, Wireless Capabilities)
  • Companies Mentioned: Abbott Laboratories; Medtronic Inc.; Koninklijke Philips N.V.; Boston Scientific Corporation; ZOLL Medical Corporation; St. Jude Medical Inc.; BIOTRONIK SE & Co. KG; Nihon Kohden Corporation; Fukuda Denshi Co. Ltd.; LivaNova PLC; MicroPort Scientific Corporation; Japan Lifeline Co. Ltd.; AtriCure Inc.; Physio-Control Inc.; BPL Medical Technologies Private Limited; Kestra Medical Technologies Inc.; CU Medical Germany GmbH; Metrax GmbH; Intermedics Inc.; Sorin Group S.p.A.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Implantable Cardioverter Defibrillators (ICDs) Market Characteristics

3. Implantable Cardioverter Defibrillators (ICDs) Market Trends And Strategies

4. Implantable Cardioverter Defibrillators (ICDs) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Implantable Cardioverter Defibrillators (ICDs) Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Implantable Cardioverter Defibrillators (ICDs) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Implantable Cardioverter Defibrillators (ICDs) Market Growth Rate Analysis
  • 5.4. Global Implantable Cardioverter Defibrillators (ICDs) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Implantable Cardioverter Defibrillators (ICDs) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Implantable Cardioverter Defibrillators (ICDs) Total Addressable Market (TAM)

6. Implantable Cardioverter Defibrillators (ICDs) Market Segmentation

  • 6.1. Global Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single Chamber Implantable Cardioverter Defibrillators (ICDs)
  • Dual Chamber Implantable Cardioverter Defibrillators (ICDs)
  • Biventricular Devices
  • 6.2. Global Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bradycardia
  • Tachycardia
  • Heart Failure
  • Other Applications
  • 6.3. Global Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Other End Users
  • 6.4. Global Implantable Cardioverter Defibrillators (ICDs) Market, Sub-Segmentation Of Single Chamber Implantable Cardioverter Defibrillators (ICDs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Standard Single Chamber ICDs
  • MRI-Compatible Single Chamber ICDs
  • Wireless Single Chamber ICDs
  • 6.5. Global Implantable Cardioverter Defibrillators (ICDs) Market, Sub-Segmentation Of Dual Chamber Implantable Cardioverter Defibrillators (ICDs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Standard Dual Chamber ICDs
  • MRI-Compatible Dual Chamber ICDs
  • Wireless Dual Chamber ICDs
  • 6.6. Global Implantable Cardioverter Defibrillators (ICDs) Market, Sub-Segmentation Of Biventricular Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • CRT-D (Cardiac Resynchronization Therapy Defibrillator)
  • CRT-P (Cardiac Resynchronization Therapy Pacemaker)
  • Biventricular ICDs With Advanced Features (Remote Monitoring, Wireless Capabilities)

7. Implantable Cardioverter Defibrillators (ICDs) Market Regional And Country Analysis

  • 7.1. Global Implantable Cardioverter Defibrillators (ICDs) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Implantable Cardioverter Defibrillators (ICDs) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Implantable Cardioverter Defibrillators (ICDs) Market

  • 8.1. Asia-Pacific Implantable Cardioverter Defibrillators (ICDs) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Implantable Cardioverter Defibrillators (ICDs) Market

  • 9.1. China Implantable Cardioverter Defibrillators (ICDs) Market Overview
  • 9.2. China Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Implantable Cardioverter Defibrillators (ICDs) Market

  • 10.1. India Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Implantable Cardioverter Defibrillators (ICDs) Market

  • 11.1. Japan Implantable Cardioverter Defibrillators (ICDs) Market Overview
  • 11.2. Japan Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Implantable Cardioverter Defibrillators (ICDs) Market

  • 12.1. Australia Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Implantable Cardioverter Defibrillators (ICDs) Market

  • 13.1. Indonesia Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Implantable Cardioverter Defibrillators (ICDs) Market

  • 14.1. South Korea Implantable Cardioverter Defibrillators (ICDs) Market Overview
  • 14.2. South Korea Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Implantable Cardioverter Defibrillators (ICDs) Market

  • 15.1. Western Europe Implantable Cardioverter Defibrillators (ICDs) Market Overview
  • 15.2. Western Europe Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Implantable Cardioverter Defibrillators (ICDs) Market

  • 16.1. UK Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Implantable Cardioverter Defibrillators (ICDs) Market

  • 17.1. Germany Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Implantable Cardioverter Defibrillators (ICDs) Market

  • 18.1. France Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Implantable Cardioverter Defibrillators (ICDs) Market

  • 19.1. Italy Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Implantable Cardioverter Defibrillators (ICDs) Market

  • 20.1. Spain Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Implantable Cardioverter Defibrillators (ICDs) Market

  • 21.1. Eastern Europe Implantable Cardioverter Defibrillators (ICDs) Market Overview
  • 21.2. Eastern Europe Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Implantable Cardioverter Defibrillators (ICDs) Market

  • 22.1. Russia Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Implantable Cardioverter Defibrillators (ICDs) Market

  • 23.1. North America Implantable Cardioverter Defibrillators (ICDs) Market Overview
  • 23.2. North America Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Implantable Cardioverter Defibrillators (ICDs) Market

  • 24.1. USA Implantable Cardioverter Defibrillators (ICDs) Market Overview
  • 24.2. USA Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Implantable Cardioverter Defibrillators (ICDs) Market

  • 25.1. Canada Implantable Cardioverter Defibrillators (ICDs) Market Overview
  • 25.2. Canada Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Implantable Cardioverter Defibrillators (ICDs) Market

  • 26.1. South America Implantable Cardioverter Defibrillators (ICDs) Market Overview
  • 26.2. South America Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Implantable Cardioverter Defibrillators (ICDs) Market

  • 27.1. Brazil Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Implantable Cardioverter Defibrillators (ICDs) Market

  • 28.1. Middle East Implantable Cardioverter Defibrillators (ICDs) Market Overview
  • 28.2. Middle East Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Implantable Cardioverter Defibrillators (ICDs) Market

  • 29.1. Africa Implantable Cardioverter Defibrillators (ICDs) Market Overview
  • 29.2. Africa Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Implantable Cardioverter Defibrillators (ICDs) Market Competitive Landscape And Company Profiles

  • 30.1. Implantable Cardioverter Defibrillators (ICDs) Market Competitive Landscape
  • 30.2. Implantable Cardioverter Defibrillators (ICDs) Market Company Profiles
    • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Medtronic Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. ZOLL Medical Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Implantable Cardioverter Defibrillators (ICDs) Market Other Major And Innovative Companies

  • 31.1. St. Jude Medical Inc.
  • 31.2. BIOTRONIK SE & Co. KG
  • 31.3. Nihon Kohden Corporation
  • 31.4. Fukuda Denshi Co. Ltd.
  • 31.5. LivaNova PLC
  • 31.6. MicroPort Scientific Corporation
  • 31.7. Japan Lifeline Co. Ltd.
  • 31.8. AtriCure Inc.
  • 31.9. Physio-Control Inc.
  • 31.10. BPL Medical Technologies Private Limited
  • 31.11. Kestra Medical Technologies Inc.
  • 31.12. CU Medical Germany GmbH
  • 31.13. Metrax GmbH
  • 31.14. Intermedics Inc.
  • 31.15. Sorin Group S.p.A.

32. Global Implantable Cardioverter Defibrillators (ICDs) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Implantable Cardioverter Defibrillators (ICDs) Market

34. Recent Developments In The Implantable Cardioverter Defibrillators (ICDs) Market

35. Implantable Cardioverter Defibrillators (ICDs) Market High Potential Countries, Segments and Strategies

  • 35.1 Implantable Cardioverter Defibrillators (ICDs) Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Implantable Cardioverter Defibrillators (ICDs) Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Implantable Cardioverter Defibrillators (ICDs) Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer